Latest Breaking News On - Toichi takino - Page 3 : comparemela.com

InveniAI Announces Collaboration with Ono Pharmaceutical for Target Discovery

InveniAI Announces Collaboration with Ono Pharmaceutical for Target Discovery
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Toichi takinoAnita ganjooSosei heptaresKrishnan nandabalanOno pharmaceutical co ltdDiscovery research at onoCorporate communicationsInvea therapeutics incSenior executiveExecutive directorKyowa kirinInvea therapeutics

Numab Therapeutics AG: Numab Therapeutics and Ono Pharmaceutical Announce an Option and Collaboration Agreement to Develop Multi-specific Antibody NM49 for Treatment of Cancer

Numab Therapeutics AG: Numab Therapeutics and Ono Pharmaceutical Announce an Option and Collaboration Agreement to Develop Multi-specific Antibody NM49 for Treatment of Cancer
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesDavid urechStefan klotterToichi takinoOno pharmaceutical co ltdDiscovery research of onoChief executive officerSenior executive officerExecutive directorLassen sie

Numab Therapeutics and Ono Pharmaceutical Announce an Option and Collaboration Agreement to Develop Multi-specific Antibody NM49 for Treatment of Cancer

Numab Therapeutics and Ono Pharmaceutical Announce an Option and Collaboration Agreement to Develop Multi-specific Antibody NM49 for Treatment of Cancer
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesDavid urechToichi takinoOno pharmaceutical co ltdDiscovery research of onoChief executive officerSenior executive officerExecutive director

Ono Enters into a Drug Discovery Collaboration and Option Agreement with Shattuck Labs to Generate Bifunctional Fusion Proteins

/PRNewswire/ Ono Pharmaceutical Co., Ltd. (Osaka, Japan; President and CEO: Gyo Sagara; "Ono") today announced that it has entered into a drug discovery.

United statesNorth carolinaTaylor schreiberToichi takinoGyo sagaraDiscovery research of onoPrnewswire ono pharmaceutical co ltdShattuck labs incShattuck labsSenior executive officerExecutive directorOno pharmaceuticalChief executive officerAgonist redirected checkpointOno pharmaceutical co

Shattuck Labs Enters into Strategic Collaboration and License Agreement with Ono Pharmaceutical to Generate Bifunctional Fusion Proteins for the Treatment of Autoimmune and Inflammatory Diseases

AUSTIN, TX and DURHAM, NC, Feb. 13, 2024 Shattuck Labs, Inc. , a clinical-stage biotechnology company pioneering the development of bifunctional fusion proteins as a new class of biologic.

North carolinaUnited statesTaylor schreiberConor richardsonToichi takinoOno pharmaceutical co ltdDiscovery research of onoShattuck labs incExchange commissionOno pharmaceuticalChief executive officerSenior executiveExecutive directorShattuck labsAgonist redirected checkpointAnnual report